Matching-Adjusted Indirect Treatment Comparison of Tarlatamab Versus Comparator Therapies in England in Patients with Extensive-Stage Small Cell Lung Cancer Who Have Received Two or More Prior Lines of Therapy
作者
R. Takundwa,Gaurav Suri,Franziska Dirnberger,Andre Verhoek,Elizabeth Vinand,Jessie Wang,Stephen Puntis,Xerxes Pundole,Fiona Blackhall